Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ProCure Proton Centers Select RayStation® for Proton Planning

Published: Thursday, December 26, 2013
Last Updated: Thursday, December 26, 2013
Bookmark and Share
CE marking and clearance in the US for PBS is expected in early 2014.

RaySearch Laboratories AB has received two orders for its RayStation® treatment planning system from the proton treatment centers Seattle ProCure Management LLC in Seattle, Washington, and Princeton ProCure Management LLC in Princeton, New Jersey.

Tony Wong, Director of Physics at the Seattle ProCure Treatment Center and Dennis Mah, Director of Physics at the New Jersey ProCure Treatment Center, comment: “There are several reasons why we selected RayStation®. The most important benefits are the breadth of technology, high speed of planning and dose computation and ease of analysis compared to other modalities. This is the best system currently available in terms of robust optimization, computational accuracy and ease of use.”

Marc Mlyn, President of RaySearch Americas, adds: “ProCure is a well-known name in proton therapy, and given the strong partnerships between RaySearch, IBA and now Procure, we are confident that this is a big step forward for all of us and how proton planning can evolve. We are looking forward to a long and mutually beneficial partnership with ProCure Management.”

“ProCure is an organization focused on quality of care and efficient technologies. We see RaySearch as a good partner for us now and into the future, and we plan on working with them to achieve our corporate vision for improving the lives of patients with cancer by increasing access to proton therapy”, says Howard Rubin, Senior Vice President of Information Systems at ProCure.

“These orders further cement our position as the leading supplier of treatment planning software for particle therapy. Together with our customers and our partner IBA, we will continue to refine our tools for proton and carbon ion therapy to fully utilize the unique technical properties of these treatment techniques to enable cancer treatments of the highest precision”, says Johan Löf, CEO of RaySearch Laboratories.

The current version of RayStation® that has FDA clearance supports the proton treatment techniques Uniform Scanning and Double Scattering.

Support for PBS / IMPT has been released in Europe with CE marking and 510(k) clearance in the US for PBS is expected in early 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Distribution Agreement in Saudi Arabia and Jordan
TMSJ assumes full responsibility for the marketing, sales and service of RayStation.
Friday, July 10, 2015
UMCG and RaySearch Initiate Collaboration Within Adaptive Radiation Therapy
RaySearch receives an order for RayStation® treatment planning system from UMCG.
Monday, October 14, 2013
RaySearch and IBA to Increase Proton Therapy Precision
Collaboration agreement signed on the development of proton treatment planning system.
Thursday, May 23, 2013
Scientific News
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Fix for 3-Billion-Year-Old Genetic Error
Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!